|
H10: manufacturing review: a complaint history review was performed.This is the first complaint reported for this product/lot number combination.Therefore, a device fistory record review is not required investigation summary: the device was returned for evaluation.There was no evidence of peeling hydrophilic coating observed on the sheath.A yellow gel like substance was present sporadically commencing 100mm from the sheath tip along the sheath for a section of 95mm.Hydrophilic coating was absent along this section of the sheath.It is unlikely that the gel substance is manufacturing related as halo one devices are 100% inspected during production.The source of the gel substance is unknown.Therefore, the result of the investigation is unconfirmed for the reported unraveled material issue.The root cause for the reported unraveled material issue could not be determined based upon the available information received from the field communications and device evaluation.Labeling review: instructions for use for the halo one thin-walled guiding sheath was reviewed and the following sections are applicable: indication for use the halo one¿ thin-walled guiding sheath is indicated for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices.The halo one¿.Thin-walled guiding sheath is not indicated for use in the neurovasculature or the coronary vasculature.Device description the halo one¿ thin-walled guiding sheath is designed to perform as both a guiding sheath and an introducer sheath.The halo one¿ thin-walled guiding sheath consists of a thin-walled (up to 1f reduction in outer diameter compared to standard sheaths of equivalent french size) sheath made from braided single-lumen tubing, fitted with a female luer hub at the proximal end and a formed atraumatic distal tip.The thin-wall design reduces the thickness of the sheath wall to help facilitate intravascular access from access sites including but not limited to radial, femoral, popliteal, tibial, and pedal.Warnings 4.Visually inspect the packaging to verify that the sterile barrier is intact.Do not use if the sterile barrier is opened or damaged.Precautions 1.The halo one¿ thin-walled guiding sheath shall only be used by trained physicians.Access procedures should be conducted under fluoroscopic guidance with appropriate x-ray equipment and / or ultrasound.5.The pouch should be inspected prior to opening to ensure the sterile barrier is not compromised.The device should be carefully removed and placed in the sterile field.The entire procedure from skin puncture or incision to sheath withdrawal must be carried out aseptically.6.Carefully inspect the sheath prior to use to verify that the sheath has not been damaged during shipment and that its size, shape and condition are suitable for the procedure for which it is to be used.Do not use if product damage is evident.21.In order to activate the hydrophilic coating, it is recommended to wet the halo one¿ thin-walled guiding sheath with heparinized saline solution immediately prior to its insertion in the body.Failure to activate the coating may lead to sub-optimal trackability of the sheath.To maintain lubricity this surface must be kept completely wet.Storage store in a cool, dry, dark place.Rotate inventory so that the catheter and other dated products are used prior to the ¿use by¿ date.Do not use if packaging is damaged or opened.Directions for use: 0.035" (0.89 mm) guidewire or 0.018" (0.46 mm) guidewire as labeled per device.Halo one¿ thin-walled guiding sheath preparation 1.Verify the french size is suitable for the procedure and can accommodate the required procedural devices as labeled (figure 3).Remove sheath and dilator from package.Halo one¿ thin-walled guiding sheath preparation 5.In order to activate the hydrophilic coating, where labeled, it is recommended to wet the halo one¿ thin-walled guiding sheath with sterile saline solution immediately prior to its insertion in the body.H10: d4 (expiration date: 02/2024), g3, h6 (device).H11: h6 (method, result, conclusion).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|